新型通用疫苗可以缓解新出现的禽流感病毒
Yu Liu1, Lifang Wang2, Alexander Lai3
1Department of Radiology, Zhuhai Clinical Medical College of Jinan University, Zhuhai People's Hospital, The Affiliated Hospital of Beijing Institute of Technology, Zhuhai, China; Institute of interventional and intelligent Medical Engineering, Jinan University, Zhuhai, China.
Trends in molecular medicine
|March 27, 2025
概括
禽流感病毒 (AIV) 构成全球威胁. 新的疫苗技术,生物信息学和人工智能为开发通用疫苗以控制快速演变的AIV菌株提供了有希望的战略.
科学领域:
- 兽医病毒学 兽医病毒学
- 公共卫生 公共卫生
- 疫苗开发 疫苗开发
背景情况:
- 禽流感病毒 (AIV) 由于频繁的溢出效应和地理传播,造成了重大的经济和公共卫生风险.
- 病毒的遗传多样性和快速演变为传统的控制方法带来了挑战.
研究的目的:
- 审查疫苗技术,生物信息学和人工智能的最新进展,以控制禽流感病毒 (AIV).
- 讨论开发针对多样化和快速演变的AIV菌株有效的通用疫苗的前景.
主要方法:
- 对最近的科学出版物和研究进行文献评论.
- 分析疫苗开发,生物信息学和人工智能的新兴技术.
- 综合当前关于通用AIV疫苗策略的观点.
主要成果:
- 最近的技术进步为准基因多样化的AIV提供了新的方法.
- 生物信息学和人工智能对于理解和预测病毒演变至关重要.
- 疫苗平台的进步为针对AIV的广泛保护提供了潜力.
结论:
- 开发通用疫苗对于有效控制禽流感病毒 (AIV) 至关重要.
- 集成先进技术是克服AIV快速发展所带来的挑战的关键.
- 对于全球卫生安全而言,对通用AIV疫苗的持续研究和开发至关重要.
更多相关视频
相关概念视频
00:57Viral Recombination
23.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.2K
00:36Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
01:51Vaccinations
43.1K
Overview
43.1K
00:42Cross-reactivity
30.9K
Overview
30.9K